Just read Drug Discovery Platform Verseon Launches Blockchain-Based Securities Exchange

Drug Discovery Platform Verseon Launches Blockchain-Based Securities Exchange

U.S. pharmaceutical company Verseon has become the latest medical organization to experiment in blockchain technology, it confirmed in a press release Tuesday, September 18. Verseon’s main product is its proprietary physics-based drug discovery platform. The company was established in 2002 and it now trades on the London Stock Exchange, boasting a market cap of £211 million ($277 million). “By democratizing investment access with blockchain technology, we will change the way new medicines and other life-science innovations are funded and how the resulting proceeds are shared,” Verseon CEO Adityo Prakash commented. The move marks a continuation of the innovation which is ongoing in the wider health industry this year.

Read the full article at cointelegraph

Wednesday, September 19, 2018